Genetic testing for autism is typically ordered through a medical geneticist, developmental pediatrician, or a specialized clinic with experience in developmental disorders. Your primary care doctor or pediatrician can refer you to one of these specialists, and in many cases health insurance covers the cost when a doctor recommends the test. The process starts with a referral, not a walk-in appointment or an at-home kit.
Which Specialists Order the Test
Three types of providers most commonly handle genetic testing for autism: medical geneticists, neurodevelopmental pediatricians, and child neurologists. These specialists work in hospital systems, university medical centers, and dedicated autism or developmental disorders clinics. A genetic counselor often works alongside them to explain what the test can and cannot reveal, and to help interpret results afterward.
If you’re not sure where to start, ask your child’s pediatrician or your own primary care doctor for a referral. They can point you toward a local genetics clinic or a developmental center that routinely orders these tests. Many children’s hospitals have dedicated genetics departments that see autism-related referrals regularly.
How to Find a Genetics Clinic Near You
The National Society of Genetic Counselors (NSGC) maintains a searchable online directory of genetic counselors across the United States and Canada. The American Board of Genetic Counseling (ABGC) has a similar directory that covers certified counselors worldwide. In Canada specifically, the Canadian Association of Genetic Counsellors (CAGC) offers its own search tool. These directories let you filter by location and specialty, making it straightforward to find someone with experience in autism-related genetics.
University-affiliated medical centers are another reliable option. Most academic hospitals have clinical genetics departments that accept referrals for autism genetic testing. Wait times can be long at these centers, sometimes several months, so getting a referral placed early helps.
What the Testing Involves
The first-line genetic test for autism is called chromosomal microarray analysis. It looks for missing or duplicated sections of DNA that are associated with developmental conditions. This test identifies a genetic cause in roughly 7 to 9 percent of autistic individuals. A simple blood draw is all that’s needed.
Fragile X syndrome testing is also standard. The CDC recommends that any child with unexplained developmental delay, intellectual disability, or autism receive genetic testing for Fragile X. Family history can offer clues: tremors or balance problems in older male relatives, or early menopause or fertility difficulties on the maternal side, may point toward an unrecognized Fragile X mutation in the family. Some children with Fragile X have physical features like prominent ears or a long face, but many show no outward signs at all.
If the initial tests come back negative, a more comprehensive option called whole exome sequencing may be recommended. This analyzes the protein-coding portions of nearly every gene. Its diagnostic yield for autism ranges from about 8 to 25 percent across studies, with a typical result around 15 percent. Some countries and insurance plans now cover this as a second-tier test, particularly for children with more severe presentations or families with multiple autistic members.
Why the Results Matter
A positive genetic finding does more than provide an explanation. It changes how doctors monitor your child’s health going forward. Many genetic conditions linked to autism carry specific medical risks that wouldn’t otherwise be screened for.
For example, up to 20 percent of children with Fragile X syndrome develop seizures, and doctors will also watch for joint problems, hernias, and heart valve issues. Children diagnosed with Angelman syndrome typically need an EEG to screen for seizures early. Tuberous sclerosis, another autism-associated condition, requires regular brain imaging, kidney scans, and heart monitoring because of tumor growth risks. In rare conditions like Timothy syndrome, an undetected heart rhythm abnormality can be fatal, but it’s manageable once identified.
Knowing the specific genetic cause lets your medical team anticipate problems before they develop rather than react to them after symptoms appear. In some cases, this is genuinely lifesaving.
Insurance and Cost
Health insurance often covers genetic testing when a doctor orders it, but policies vary. Some plans cover chromosomal microarray readily but require additional justification for whole exome sequencing. Contact your insurance company before testing to confirm what’s covered and whether prior authorization is needed. The genetics clinic or genetic counselor’s office can usually help with this process, since they navigate insurance approvals routinely.
If cost is a barrier, research studies offer another pathway. The SPARK study, run by the Simons Foundation, provides free genetic testing to autistic individuals and their families. The trade-off is that SPARK is a research program, not a clinical service. Results are only returned if a specific genetic change associated with autism is found, and even then, the timeline is slower than a clinical lab. Research results also can’t substitute for a clinical-grade test in your medical record. Still, for families without insurance coverage or facing long wait lists, research participation can be a valuable starting point.
Why Consumer DNA Kits Aren’t Enough
Direct-to-consumer DNA tests like 23andMe or AncestryDNA are not designed to detect the genetic changes associated with autism. Clinical genetic testing uses different technology, runs through certified laboratories, and produces results that your doctor can act on. Consumer kits look at a limited set of genetic markers chosen for ancestry and common health traits. They don’t perform the chromosomal microarray or exome-level analysis needed to identify autism-related variants.
If you’ve already done a consumer test, the raw data can sometimes be uploaded to third-party analysis tools, but this is not a replacement for clinical testing. The results won’t be accepted by insurance companies or medical providers as a basis for treatment decisions. For actionable, medically meaningful results, clinical testing through a qualified specialist remains the standard.